Health Condition 1: null- Newly diagnosed patients of dyslipidimia
Conditions
Interventions
None listed
Sponsors
Dr Jahnavi Maini
Eligibility
Inclusion criteria
Inclusion criteria: Treatment naive dyslipidemic patients (Low-density lipoprotein >=100mg/dl) or patients with ASCVD having dyslipidemia requiring statin therapy.
Exclusion criteria
Exclusion criteria: 1. Patient with comorbid Type 1 and Type 2 Diabetes Mellitus. 2. Patients prescribed lipid lowering agents other than statins. 3. Any known history of condition(s) which may cause secondary dyslipidemia (e.g. nephrotic syndrome, glycogen storage disease etc.). 4. Any history of condition(s) which may affect euglycemia (pancreatic impairment or disease). 5. History of previous or current muscular or neuromuscular disease. 6. History of drugs which impair lipid profile or glycemic parameters.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To estimate and compare the change in serum adipsin levels in dyslipidemic patients from baseline with that of serum adipsin levels after 12 weeks of statin therapyTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 2. To study the correlation of serum adipsin levels with serum insulin & HbA1c levels following 12 weeks of statin therapyTimepoint: 12 weeks;To estimation and comparison of serum levels of adipsin (mean ± SD) in statin treatment group and NHVTimepoint: baseline | — |
Countries
India
Contacts
Public ContactDr Jahnavi Maini
Lady Hardinge Medical College
Outcome results
None listed